Literature DB >> 3653855

A population study on the prevalence of gallstone disease: the Sirmione Study.

L Barbara1, C Sama, A M Morselli Labate, F Taroni, A G Rusticali, D Festi, C Sapio, E Roda, C Banterle, A Puci.   

Abstract

The prevalence of gallstone disease (cholelithiasis and previous cholecystectomy for gallstones) in the population of the town of Sirmione, Italy, examined by ultrasonography, was 6.7% in men and 14.6% in women, ranging from 18 to 65 yr of age (overall prevalence = 11%). The prevalence of cholelithiasis in the same age span was 6.9% (4.5% in men and 8.9% in women). Prevalence of cholelithiasis increased with age in both sexes. Twenty-two percent of gallstone subjects suffered from biliary pain vs. 2% of subjects without gallstones. No difference was observed in the frequency of nonspecific symptoms between subjects with and without gallstones. Of the 132 gallstone subjects, 108 (82%) were not aware of having gallstones prior to the study. Prevalence of gallstone disease was found to be higher in obese and hypertriglyceridemic subjects and to increase with the number of pregnancies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3653855     DOI: 10.1002/hep.1840070520

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  124 in total

Review 1.  Cholesterol gallstones: from epidemiology to prevention.

Authors:  M Acalovschi
Journal:  Postgrad Med J       Date:  2001-04       Impact factor: 2.401

2.  Could gastrointestinal disorders differ in two close but divergent social environments?

Authors:  Ewa Grodzinsky; Claes Hallert; Tomas Faresjö; Elisabet Bergfors; Ashild Olsen Faresjö
Journal:  Int J Health Geogr       Date:  2012-02-06       Impact factor: 3.918

Review 3.  Controversies concerning pathophysiology and management of acalculous biliary-type abdominal pain.

Authors:  Amit Rastogi; Adam Slivka; Arthur James Moser; Arnold Wald
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

4.  Prevalence of cholelithiasis among persons undergoing abdominal ultrasound at the Komfo Anokye Teaching Hospital, Kumasi, Ghana.

Authors:  Adam Gyedu; Kwadwo Adae-Aboagye; Augustina Badu-Peprah
Journal:  Afr Health Sci       Date:  2015-03       Impact factor: 0.927

Review 5.  Acute non-traumatic maternal illnesses in pregnancy: imaging approaches.

Authors:  Saween K S Thompson; Stanford M Goldman; Komal B Shah; Phebe C Chen; Louis K Wagner; Frank M Corl; Bharat K Raval; Shela Sheth; Elliot K Fishman; Carl M Sandler
Journal:  Emerg Radiol       Date:  2005-06

Review 6.  Evaluation of the biliary tract in patients with functional biliary symptoms.

Authors:  Peter Funch-Jensen; Asbjørn Mohr Drewes; László Madácsy
Journal:  World J Gastroenterol       Date:  2006-05-14       Impact factor: 5.742

Review 7.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

8.  Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism.

Authors:  G T Everson; C McKinley; F Kern
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

9.  Usefulness of gallbladder ejection fraction estimation to predict the recurrence of biliary pain in patients with symptomatic gallstones who did not undergo cholecystectomy.

Authors:  Sung Noh Hong; Jong Kyun Lee; Kyu Taek Lee; Jin Seok Heo; Seong Ho Choi; Poong Lyul Rhee; Seung Woon Paik; Byung Chul Yoo; Jong Chul Rhee
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

10.  Androgen-deprivation therapy and risk for biliary disease in men with prostate cancer.

Authors:  Philip J Saylor; Matthew R Smith; A James O'Malley; Nancy L Keating
Journal:  Eur Urol       Date:  2013-02-12       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.